GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Yunkang Group Ltd (HKSE:02325) » Definitions » EV-to-EBITDA

Yunkang Group (HKSE:02325) EV-to-EBITDA : -129.00 (As of Jun. 07, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Yunkang Group EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Yunkang Group's enterprise value is HK$6,102.6 Mil. Yunkang Group's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-47.3 Mil. Therefore, Yunkang Group's EV-to-EBITDA for today is -129.00.

The historical rank and industry rank for Yunkang Group's EV-to-EBITDA or its related term are showing as below:

HKSE:02325' s EV-to-EBITDA Range Over the Past 10 Years
Min: -129.26   Med: 12.67   Max: 241
Current: -129

During the past 6 years, the highest EV-to-EBITDA of Yunkang Group was 241.00. The lowest was -129.26. And the median was 12.67.

HKSE:02325's EV-to-EBITDA is ranked worse than
100% of 110 companies
in the Medical Diagnostics & Research industry
Industry Median: 15.91 vs HKSE:02325: -129.00

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-07), Yunkang Group's stock price is HK$10.94. Yunkang Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-0.185. Therefore, Yunkang Group's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Yunkang Group EV-to-EBITDA Historical Data

The historical data trend for Yunkang Group's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yunkang Group EV-to-EBITDA Chart

Yunkang Group Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial - - - 13.45 253.03

Yunkang Group Semi-Annual Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only - - 13.45 - 253.03

Competitive Comparison of Yunkang Group's EV-to-EBITDA

For the Diagnostics & Research subindustry, Yunkang Group's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Yunkang Group's EV-to-EBITDA Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Yunkang Group's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Yunkang Group's EV-to-EBITDA falls into.



Yunkang Group EV-to-EBITDA Calculation

Yunkang Group's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=6102.563/-47.307
=-129.00

Yunkang Group's current Enterprise Value is HK$6,102.6 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Yunkang Group's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-47.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Yunkang Group  (HKSE:02325) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Yunkang Group's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=10.94/-0.185
=At Loss

Yunkang Group's share price for today is HK$10.94.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Yunkang Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-0.185.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Yunkang Group EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Yunkang Group's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Yunkang Group (HKSE:02325) Business Description

Traded in Other Exchanges
N/A
Address
No. 6 Lizhishan Road, Science City, Huangpu District, Guangzhou, CHN
Yunkang Group Ltd is a medical operation service provider in China. The company has three major business lines namely covering diagnostic testing services for medical consortia, diagnostic outsourcing services, and non-medical institutions.
Executives
Huizekx Limited 2201 Interest of corporation controlled by you
Yk Development Limited 2101 Beneficial owner
Zhang Yong 2201 Interest of corporation controlled by you
Shanghai Pudong Development Bank Co., Ltd 2201 Interest of corporation controlled by you
Zhou Xinyu
Guang Zhou Da An Ji Yin Gu Fen You Xian Gong Si 2201 Interest of corporation controlled by you
Da An Guo Ji Ji Tuan You Xian Gong Si 2101 Beneficial owner
Guang Zhou Shi Da An Ji Yin Ke Ji You Xian Gong Si 2201 Interest of corporation controlled by you
Jin Jun Ying Limited 2201 Interest of corporation controlled by you
Mouduans Limited 2201 Interest of corporation controlled by you
Source Capital Rw Limited 2201 Interest of corporation controlled by you
Tongfuzc Limited 2201 Interest of corporation controlled by you
Wjjr Investment Limited 2201 Interest of corporation controlled by you

Yunkang Group (HKSE:02325) Headlines

No Headlines